statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	508
IT - Italia	324
CN - Cina	256
SG - Singapore	192
HK - Hong Kong	74
GB - Regno Unito	53
BR - Brasile	50
VN - Vietnam	44
DE - Germania	33
RU - Federazione Russa	32
KR - Corea	30
ID - Indonesia	25
SE - Svezia	18
FI - Finlandia	16
NL - Olanda	14
CA - Canada	12
LT - Lituania	10
FR - Francia	9
TR - Turchia	9
IQ - Iraq	8
AT - Austria	7
AR - Argentina	6
PL - Polonia	6
UA - Ucraina	6
ES - Italia	5
MX - Messico	5
CO - Colombia	4
IN - India	4
ZA - Sudafrica	4
CH - Svizzera	3
IL - Israele	3
JP - Giappone	3
BD - Bangladesh	2
BE - Belgio	2
EC - Ecuador	2
EG - Egitto	2
IE - Irlanda	2
MA - Marocco	2
PK - Pakistan	2
PY - Paraguay	2
RO - Romania	2
TN - Tunisia	2
TW - Taiwan	2
AE - Emirati Arabi Uniti	1
AU - Australia	1
AZ - Azerbaigian	1
BH - Bahrain	1
CI - Costa d'Avorio	1
CL - Cile	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EE - Estonia	1
GR - Grecia	1
IR - Iran	1
IS - Islanda	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LY - Libia	1
MD - Moldavia	1
PT - Portogallo	1
SA - Arabia Saudita	1
TZ - Tanzania	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.817

Nome	#
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles	208
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines	206
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury	199
Challenges of enzyme therapy: Why two players are better than one	159
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease	151
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization	151
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136))	142
The key role of public health in renovating Italian biomedical doctoral programs	138
Tunneling Nanotubes: A New Target for Nanomedicine?	134
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments	133
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy	107
Quantitative comparison of the protein corona of nanoparticles with different matrices	99
Totale	1.827

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	87	0	0	3	4	11	4	1	13	15	7	13	16
2023/2024	258	11	20	22	29	39	20	17	30	5	22	18	25
2024/2025	758	32	10	22	47	110	91	70	41	96	37	95	107
2025/2026	724	141	96	113	167	173	34	0	0	0	0	0	0
Totale													1.827